Summit Therapeutics partners with GSK for cancer drug combination trial
Go back to Summit Therapeutics partners with GSK for cancer drug combination trial| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.43 -0.64 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.07 | 52 Week High | $45.58 | |||
| Open | $51.90 | 52 Week Low | $37.82 | |||
| Day High | $52.09 | P/E | N/A | |||
| Day Low | $51.40 | EPS | $0.00 | |||
| Volume | 1,716,709 | |||||
| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 14.23 +0.87 (6.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.36 | 52 Week High | $19.75 | |||
| Open | $14.75 | 52 Week Low | $4.26 | |||
| Day High | $15.10 | P/E | N/A | |||
| Day Low | $14.11 | EPS | $0.00 | |||
| Volume | 11,631,480 | |||||
